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Few would argue with the need for long term follow up
following endovascular repair of abdominal aortic aneu-
rysms. A small risk of reintervention persists and the chal-
lenge remains to identify those patients that will require
additional procedures to prevent subsequent complications.
The ideal follow up regimen remains elusive. Up until this
point, most regimens have consisted of radiologic imaging,
with either CT scans or ultrasonography to identify continued
aneurysmperfusion (endoleaks) and document sac dynamics,
either shrinkage, growth or stability. However, aneurysm sac
growth or shrinkage serves only as a surrogate measurement
for pressurisation and although its uniformly believed that
attachment site endoleaks require treatment, it remains
controversial as to how to determine which Type II endoleaks
pressurise an aneurysm sufficiently to require therapy.
In response to these difficulties several manufacturers
have developed pressure sensors that can be implanted at
the time of the initial repair. They’ve been shown capable
of measuring intra-sac pressures that have appropriately
responded to reinterventions for endoleaks. However, are
they the answer we’re looking for? Are they ready for
widespread use? Do they offer a reliable and consistent
measure of intra-sac pressure that can be trusted toDOI of original article: 10.1016/j.ejvs.2010.11.009, 10.1016/
j.ejvs.2010.11.010
) This paper is also being published in the Journal of Vascular
Surgery.
* Corresponding author. Vascular Surgery Department, University of
Poitiers, Medical School, 86021 Poitiers, France.Tel.:þ33 5 49 44 38 46;
fax: þ33 5 49 50 05 50.
E-mail address: jeanbaptistericco@gmail.com (J.-B. Ricco).determine the need, or lack of need, for further therapy?
Our debaters will try to convince us one way or another.
doi: 10.1016/j.ejvs.2010.11.011
Part One: For the Motion.
Serial Sac Pressure Measurements
can Determine Which Type II
Endoleaks can be TreatedR. Milner *Division of Vascular Surgery and Endovascular Therapy,
Loyola University, Stritch School of Medicine,
2160 South First Avenue, Maywood, IL 60153, USAIntroduction
Repair of abdominal aortic aneurysms (AAA) was revolu-
tionized by the introduction of endovascular aneurysm
repair (EVAR) by Dr. Juan Parodi.1 The devices utilized to
treat aortic aneurysms have improved significantly since his
initial report in 1991. Therefore, the incidence of device-
related endoleaks (type I and III) occurs less frequently in
this 3rd decade of EVAR as compared to when devices first
received FDA approval. On the other hand, type II endo-
leaks remain controversial. The branch vessel filling of the
sac (e.g. inferior mesenteric artery and lumbar arteries)
leads to variability in the behavior of the residual aneurysm
sac.
Pressure sensing technology (CardioMEMS, Inc., Atlanta,
GA) has been proven efficacious in the acute exclusion of
aneurysms with an endograft.2 Long-term surveillance with
pressure sensors is still being evaluated. I hope to demon-
strate to you that I am correct about the utility of pressure
sensors to determine therapy for type II endoleaks as
opposed to Professor Cao’s opinion that there is no benefit
for pressure sensing in relationship to type II endoleaks.To access continuing medical education questions on this
paper, please go to www.vasculareducation.com and click on ‘CME’.
* Tel.: þ1 708 327 3431; fax: þ1 708 327 3492.
E-mail address: rmilner@lumc.edu.
Figure 2 Sac pressure tracing from a patient with an
elevated pressure and expanding aneurysm sac. The sac has
grown from 5.2 to 5.7 cm with a ratio of 0.4.
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As mentioned above, pressure sensors have been shown
to be effective in determining the acute exclusion of an
aneurysm treated with an endograft. There is more
evidence in the literature that sensors are effective for
longer-term surveillance as well.3,4 These two studies show
the efficacy of sensors in surveillance after EVAR and TEVAR
in relation to both type I and type III endoleaks. Both
studies show that, in general, the measured pressure is
reduced as the residual aneurysm sac shrinks except when
a type I or III endoleak is present. Hoppe and colleagues3
reported only two type II endoleaks in their series of
patients treated for abdominal aortic aneurysms. Both of
these leaks were associated with a low residual sac pulse
pressure. Parsa and colleagues4 followed 7 patients with
type II endoleaks after TEVAR. Once again, the residual sac
pulse pressure was low and the aneurysm sacs were not
enlarging.
Ellozy and colleagues presented their experience at Mt.
Sinai in New York with a pressure-sensing technology that is
not being utilized currently (Remon Medical Technologies,
Caesarea, Israel).5 This technology is based on ultrasound
rather then radiofrequency (CardioMEMS), but serves an
identical purpose of sac pressure monitoring. Their expe-
rience was small, overall, but a few patients had type II
endoleaks. The pressure was elevated in two patients with
type II endoleaks. These two patients did not have sac
expansion. Several others had type II endoleaks with either
low residual sac pressure or a resolved endoleak on follow-
up imaging.
Personal Experience
We placed almost 70 remote pressure sensors (CardioMEMS)
in patients at Emory University Hospital undergoing endo-
vascular abdominal aortic aneurysm repair over a two-year
period of time. In addition, we were one of the eleven sites
in the APEX trial. Most patients had low residual pulseFigure 1 Sac pressure tracing from a patient with a type II
endoleak and a shrinking aneurysm sac. The residual pulse
pressure is 6 mm Hg with a ratio of 0.06 (sac pulse pressure/
systemic pulse pressure).pressure in the sac that correlated well with exclusion,
both in the short term and on follow-up surveillance.
Several type I endoleaks were treated intra-operatively.
And, two type III endoleaks were detected on follow-up
surveillance and treated with cuff placement for iliac limb
modular disconnections. Both patients had expanding
aneurysm sacs and elevated pulse pressures. One type III
endoleak was seen at 6-month follow-up. The second was
noted on two-year evaluation. Both patients have been
problem-free since their secondary intervention with cuff
placement. The residual pulse pressure was very low in
both with shrinking aneurysm sacs.
Consistent with the published literature, our experience
with type II endoleaks has been limited. I have two
examples that will help explain the potential of pressure-
sensing for the detection of type II endoleaks. The first
patient had a low residual pulse pressure and a shrinking
aneurysm sac (Fig. 1). The second patient has an elevated
pulse pressure and an expanding aneurysm sac (Fig. 2). This
patient was diagnosed with an intra-cranial malignancy just
prior to his planned secondary intervention. Therefore, his
procedure was cancelled. He has not had follow-up since
that time.Treatment of Type II Endoleaks
So, does pressure-sensing determine which type II endo-
leaks need to be treated? I think the answer is “yes” and
“no” with the current literature support. An elevated
pressure in association with an expanding aneurysm sac
needs to be treated. A low residual pulse pressure with
a stable or shrinking sac does not need treatment. The grey
zone is more difficult to determine.
There is not an absolute number or residual pulse pres-
sure that can be utilized to make a decision to treat a type
II endoleak. I hope that as experience grows with pressure
sensors in the literature that type II treatment will be
better described. It would be ideal to treat an aneurysm
based on residual pulse pressure prior to aneurysm sac
expansion and the risk of rupture.
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Measuring Intra-sac Pressure
Measurements is of No Benefit to the
PatientP. De Rango a, F. Verzini a, P. Cao b,*aChirurgia Vascolare ed Endovascolare, Ospedale S. Maria
della Misericordia, Perugia, Italy
bChirurgia Vascolare, Dipartimento di Cardioscienze,
Azienda Ospedaliera S. Camillo e Forlanini, Roma, Italy
The goal of any treatment of aortic aneurysm is to prevent
rupture. From an endovascular standpoint this purpose is
achieved by eliminating flow in the aneurysm sac. Failure to
completely exclude the aneurysm from systemic circulation
(e.g. endoleak, endotension) results in continued pressur-
isation and persisting risk of expansion/rupture. Measure-
ment of sac pressure provides a physiological assessment of
success. After the first experiences showing feasibility and
reliability of direct percutaneous translumbar intra-sac
pressure measurement with catheters1,2 the development of
minimally invasive implantable telemetric pressure sensors
was increasingly advocated in the last decade as an easy andTo access continuing medical education questions on this
paper, please go to www.vasculareducation.com and click on ‘CME’.
* Corresponding author. Tel.: þ39 075 5786436; fax: þ39 075
5786435.
E-mail address: pcao@unipg.it (P. Cao).convenient method for surveillance after endovascular
aneurysm repair. To date, three different types of pressure
sensors (all implantable at the time of the endovascular
procedure and not containing any internal energy source
battery) using different technologies of transmitting the
pressure from inside the body to an external antenna have
been investigated. The Impressure AAA Sac Pressure Sensor
(Remon Medical Technologies, Caesarea, Israel) is ultra-
sound-based (ultrasounds activate the sensor and commu-
nicate with the external device). The CardioMEMS EndoSure
Wireless AAA Pressure Sensor (CardioMems, Atlanta, GA,
USA), the only pressure sensor with FDA approval, is radio-
frequency-based and consists in a resonant circuit. The TPS
Telemetric Pressure Sensor (Helmhotz Institute for Biomed-
ical Engineering and the Institute of Materials in Electrical
Engineering, RWTH, Aachen, Germany), tested only in in-
vitro models, is based on a completely digital microchip
which transfers digital data to an external monitoring
station. In addition, a new, non-electronic technology, called
“Acoustic pressure-sensing”, is currently under development
by the Commonwealth Scientific and Industrial Research
Organization in Australia.
Even though monitoring the pressure within the aneu-
rysm sac with a catheter or an implantable sensor could be
an appealing mean to predict the risk of aneurysm rupture,
whether this physiologic monitor may obviate to the
necessity of further surveillance investigations after endo-
vascular aortic repair is debatable. Today there are notable
limitations to both direct trans-catheter and sensor pres-
sure device usage.
Clinical Relevance
Pressure monitoring has been investigated in vitro, in
animal models and in small clinical trials. Nevertheless,
since clinical trials have not yet evaluated a sufficient
number of patients over the long term, i.e. several years, it
is not clear how current protocols of surveillance after
endovascular repair might be changed without failing to
detect relevant adverse events such graft migration. Ellozy
et al., from an IDE study with Impressure AAA Sac Pressure
Transducer reported that mean pressure was significantly
lower in patients with sac shrinkage at 6 months and at final
follow-up. However, pressure could be obtained only in 15
of the 21 patients implanted.3 In 2008, two case series,
both using the EndoSure radiofrequency device, were
published.4,5 The first4 reported only on intraoperative use
in a series of 19 patients. Although statistically significant
correlation coefficients were found in all the comparisons
between pressure sensors and catheter measurements,
values largely ranged, from 0.50 to 0.96. The second case
series reported on postoperative monitoring for endoleaks
using the CardioMEMS EndoSure sensor in 12 patients with
30 day follow-up.5 Delivery of the sensor was complicated
in 7% with no obtainable pressure reading.5 In the APEX
study (Acute Pressure measurement to confirm aneurysm
sac Exclusion) the initial sensor pressure measurements
matched with the angiographic catheter pressure
measurements of type I and III endoleak. However, of 90
enrolled patients results were not reported in 14 due to
“protocol violations, typically a missed measurement”.6
